Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2023

Sep 1, 2023

34129_dirs_2023-09-01_ada5a91c-7712-4b84-9198-47dabdc357e1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2023-08-30

Reporting Person: HURWITZ EDWARD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-08-30 Common Stock P 15000 $4.91 Acquired 33074 Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $4.90 to $4.91. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.